Logo image of BHM

BLUEROCK HOMES TRUST INC (BHM) Stock Fundamental Analysis

NYSEARCA:BHM - NYSE Arca - US09631H1005 - REIT - Currency: USD

10.32  +0.03 (+0.28%)

Fundamental Rating

2

BHM gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 20 industry peers in the Residential REITs industry. BHM has a bad profitability rating. Also its financial health evaluation is rather negative. BHM does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BHM has reported negative net income.
In the past year BHM had a positive cash flow from operations.
In the past 5 years BHM reported 4 times negative net income.
BHM had a positive operating cash flow in each of the past 5 years.
BHM Yearly Net Income VS EBIT VS OCF VS FCFBHM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

BHM's Return On Assets of -0.44% is on the low side compared to the rest of the industry. BHM is outperformed by 60.00% of its industry peers.
Looking at the Return On Equity, with a value of -1.76%, BHM is doing worse than 65.00% of the companies in the same industry.
Industry RankSector Rank
ROA -0.44%
ROE -1.76%
ROIC N/A
ROA(3y)-0.42%
ROA(5y)2.73%
ROE(3y)-1.76%
ROE(5y)1.52%
ROIC(3y)N/A
ROIC(5y)N/A
BHM Yearly ROA, ROE, ROICBHM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

With a Gross Margin value of 42.53%, BHM is not doing good in the industry: 95.00% of the companies in the same industry are doing better.
BHM's Gross Margin has declined in the last couple of years.
BHM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.92%
GM growth 5YN/A
BHM Yearly Profit, Operating, Gross MarginsBHM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 200 -200 400 600

More info and screens

2

2. Health

2.1 Basic Checks

BHM does not have a ROIC to compare to the WACC, probably because it is not profitable.
BHM has more shares outstanding than it did 1 year ago.
BHM has a worse debt/assets ratio than last year.
BHM Yearly Shares OutstandingBHM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 1M 2M 3M
BHM Yearly Total Debt VS Total AssetsBHM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 0.06, we must say that BHM is in the distress zone and has some risk of bankruptcy.
BHM's Altman-Z score of 0.06 is on the low side compared to the rest of the industry. BHM is outperformed by 90.00% of its industry peers.
A Debt/Equity ratio of 1.04 is on the high side and indicates that BHM has dependencies on debt financing.
BHM has a Debt to Equity ratio (1.04) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.04
Debt/FCF N/A
Altman-Z 0.06
ROIC/WACCN/A
WACC5.09%
BHM Yearly LT Debt VS Equity VS FCFBHM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

BHM has a Current Ratio of 1.02. This is a normal value and indicates that BHM is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of BHM (1.02) is better than 80.00% of its industry peers.
BHM has a Quick Ratio of 1.02. This is a normal value and indicates that BHM is financially healthy and should not expect problems in meeting its short term obligations.
BHM has a better Quick ratio (1.02) than 85.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 1.02
BHM Yearly Current Assets VS Current LiabilitesBHM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M

More info and screens

3

3. Growth

3.1 Past

BHM shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.54%.
The Revenue has grown by 22.20% in the past year. This is a very strong growth!
BHM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 50.84% yearly.
EPS 1Y (TTM)6.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-59.77%
Revenue 1Y (TTM)22.2%
Revenue growth 3Y50.84%
Revenue growth 5YN/A
Sales Q2Q%31.49%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BHM Yearly Revenue VS EstimatesBHM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BHM. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BHM Price Earnings VS Forward Price EarningsBHM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

BHM's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. BHM is more expensive than 95.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 96.71
BHM Per share dataBHM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40 -60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.86%, BHM is a good candidate for dividend investing.
BHM's Dividend Yield is a higher than the industry average which is at 4.56.
Compared to an average S&P500 Dividend Yield of 2.40, BHM pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.86%

5.2 History

BHM is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BHM Yearly Dividends per shareBHM Yearly Dividends per shareYearly Dividends per share 2023 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

The earnings of BHM are negative and hence is the payout ratio. BHM will probably not be able to sustain this dividend level.
DP-173.26%
EPS Next 2YN/A
EPS Next 3YN/A
BHM Yearly Income VS Free CF VS DividendBHM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 100M -100M -200M

More info and screens

BLUEROCK HOMES TRUST INC

NYSEARCA:BHM (5/29/2025, 8:04:01 PM)

10.32

+0.03 (+0.28%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners35.26%
Inst Owner ChangeN/A
Ins Owners9.37%
Ins Owner Change0%
Market Cap42.00M
AnalystsN/A
Price TargetN/A
Short Float %0.19%
Short Ratio1.21
Dividend
Industry RankSector Rank
Dividend Yield 4.86%
Yearly Dividend1.87
Dividend Growth(5Y)N/A
DP-173.26%
Div Incr Years0
Div Non Decr Years0
Ex-Date12-24 2025-12-24 (0.125)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.84
P/FCF N/A
P/OCF 4.64
P/B 0.17
P/tB 0.18
EV/EBITDA 96.71
EPS(TTM)-1.1
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-61.05
FCFYN/A
OCF(TTM)2.23
OCFY21.57%
SpS12.34
BVpS59.27
TBVpS58.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.44%
ROE -1.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.53%
FCFM N/A
ROA(3y)-0.42%
ROA(5y)2.73%
ROE(3y)-1.76%
ROE(5y)1.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.92%
GM growth 5YN/A
F-Score3
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 1.04
Debt/FCF N/A
Debt/EBITDA 80.73
Cap/Depr 1194.08%
Cap/Sales 512.84%
Interest Coverage N/A
Cash Conversion 291.44%
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 1.02
Altman-Z 0.06
F-Score3
WACC5.09%
ROIC/WACCN/A
Cap/Depr(3y)728.9%
Cap/Depr(5y)962.54%
Cap/Sales(3y)349.98%
Cap/Sales(5y)565.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-59.77%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.2%
Revenue growth 3Y50.84%
Revenue growth 5YN/A
Sales Q2Q%31.49%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-26.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-3728.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-34.74%
OCF growth 3Y-2.62%
OCF growth 5YN/A